Selective serotonin re-uptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: Evidence for pleiotropic effects

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 4, Issue 4, 2006, Pages 361-367

  Paraskevaidis, Ioannis ^a   Parissis, John T ^a   Fountoulaki, Katerina ^a   Filippatos, Gerasimos ^a   Kremastinos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cardiovascular disease; Cytokines; Depression; Platelets; SSRIs

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ALPHA2B INTERFERON; ANXIOLYTIC AGENT; BETA INTERFERON; CITALOPRAM; CLOPIDOGREL; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESCITALOPRAM; FAS LIGAND; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MAPROTILINE; NORFLUOXETINE; NORTRIPTYLINE; OMEGA 3 FATTY ACID; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VON WILLEBRAND FACTOR;

ACUTE CORONARY SYNDROME; BLEEDING; BODY WEIGHT DISORDER; BYPASS SURGERY; CANCER; CARDIOTOXICITY; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEATH; DEPRESSION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; EVIDENCE BASED MEDICINE; GENERAL CONDITION DETERIORATION; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEPATITIS C; HORMONAL REGULATION; HOSPITALIZATION; HUMAN; IMMUNOSTIMULATION; MAJOR DEPRESSION; MULTIPLE SCLEROSIS; NEUROENDOCRINE SYSTEM; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PLEIOTROPY; PROGNOSIS; QT PROLONGATION; REVIEW; RISK ASSESSMENT; SEROTONIN SYNDROME; THROMBOCYTE FUNCTION; WEIGHT GAIN;

EID: 33750039360     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152506784111454     Document Type: Review

References (83)

1. Wells, K.; Stewart, A.; Hays, R.; Burnam, M.A.; Rogers, W.; Daniels, M.; Berry, S.; Greenfield, S.; Ware, J. JAMA, 1998, 262, 914.
2. Goldman, L.S.; Nielsen, N.H.; Champion, H.C. J. Gen. Intern. Med., 1999, 14, 569.
3. Havranek, E.P.; Ware, M.; Lowes, B.D. Am. J. Cardiol., 1999, 84, 348.
4. Koenig, H. Gen. Hosp. Psychiatry, 1998, 20, 29.
5. Skotzko, C.; Krichten, C.; Zietowski, G.; Alves, L.; Freudenberger, R.; Robinson, S.; Fisher, M.; Gottlieb, S.S. J. Cardiac. Fail., 2000, 6, 300.
6. Joynt, K.E.; Whellan, D.J.; O'Connor, C.M. J. Card. Fail., 2004, 10(3), 258.
7. Musselman, D.L.; Evans, D.L.; Nemeroff, C.B. Arch. Gen. Psychiatry 1998, 55, 580.
8. Rudisch, B.; Nemeroff, C.B. Biol. Psychiatry, 2003, 54, 227.
9. Jiang, W.; Krishnan, R.R,; O'Connor, C.M. CNS Drugs, 2002, 16, 111.
10. Rumsfeld, J.S.; Havranek, E.P.; Masoudi, F.; Peterson, E.D.; Jones, P.; Tooley, J.F.; Krumholz, H.M.; Spertus, J.A. J. Am. Coll. Cardiol., 2003, 42, 1811.
11. Vaccarino, V.; Kasl, S.; Abramson, J.; Krumholz, H.M. J. Am. Coll. Cardiol., 2001, 38(1), 199.
12. Murberg, T.E.; Furze, G. Med. Sci. Monit., 2004, 10(12), CR643.
13. Sullivan, M.D.; Levy, W.C.; Crane, B.A.; Russo, J.E.; Spertus, J.A. Am. J. Cardiol., 2004, 94, 1577.
14. Ruo, B.; Rumsfeld, J.S.; Hlatky, M.A.; Liu, H.; Browner, W.S.; Whooley, M.A. JAMA, 2003, 290, 215.
15. Rumsfeld, J.S.; Jones, P.G.; Whooley, M.A.; Sullivan, M.D.; Pitt, B.; Weintraub, W.S.; Spertus, J.A. Am. Heart J., 2005, 150(5), 961.
16. Burg, M.M.; Benedetto, M.C.; Rosenberg, R.; Soufer, R. Psychosom Med., 2003, 65, 111.
17. Connerney, I.; Shapiro, P.A.; McLaughlin, J.S.; Bagiella, E.; Sloan, R.P. Lancet, 2001, 358, 1766.
18. Mallik, S.; Krumholz, H.M.; Lin, Z.Q.; Kasl, S.V.; Mattera, J.A.; Roumains, S.A.; Vaccarino, V. Circulation, 2005, 111, 271.
19. Plante, G.E. Metab. Clin. Exp., 2005, 54(Suppl 1), 45.
20. Reiff, M.; Schwartz, S.; Northridge, M. Psychosom Med., 2001, 6, 711.
21. Rajagopalan, S.; Brook, R.; Rubenfire, M.; Pitt, E.; Young, E.; Pitt, B. Am. J. Cardiol., 2001, 88, 196.
22. Chrapko, W.E.; Jurasz, P.; Radomski, M.W.; Lara, N.; Archer, S.L.; Le Melledo, J.M. Biol. Psychiatry, 2004, 56, 129.
23. Parissis, J.; Adamopoulos, S.; Rigas, A.; Kostakis, G.; Karatzas, D.; Venetsanou, K.; Kremastinos, D.T. Am. J. Cardiol., 2004, 94, 1326.
24. Shimbo, D.; Chaplin, W.; Crossman, D.; Haas, D.; Davidson, K. Am. J. Cardiol., 2005, 96, 1016.
25. Parissis, J.; Fountoulaki, K.; Paraskevaidis, I.; Kremastinos, D. Expert Opin. Investig. Drugs, 2005, 14(5), 567.
26. Stein, P.K.; Carney, R.M.; Freedland, K.E.; Skala, J.A.; Jaffe, A.S.; Kleiger, R.E.; Rottman, J.N. J. Psychosom Res., 2000, 48, 493.
27. Carney, R.M.; Blumenthal, J.A.; Stein, P.K.; Watkins, L.; Catellier, D.; Berkman, L.F.; Czajkowski, S.M.; O'Connor, C.; Stone, P.H.; Freedland, K.E. Circulation, 2001, 104, 2024.
28. Grippo, A.J.; Santos, C.M.; Johnson, R.F.; Beltz, T.G.; Martins, J.B.; Felder, R.B.; Johnson, A.K. Am. J. Physiol., Heart Circ. Physiol., 2004, 286, H619.
29. DiMatteo, M.R.; Lepper, H.S.; Croghan, T.W. Arch. Intern. Med., 2000, 160, 2101.
30. Roose, S.P. Biol. Phychiatry, 2003, 54, 262.
31. Glassman, A.H.; Rouse, S.P.; Bigger, J.T. Jr. JAMA, 1993, 269, 2673.
32. Sheline, Y.I; Freedland, K.E.; Carney, R.M. Am. J. Med., 1997, 102, 54.
33. Song, F.; Freemantle, N.; Sheldon, T.A.; House, A.; Watson, P.; Long, A.; Mason, J. Br. Med. J., 1993, 306, 683.
34. Carrasco, J.L.; Sandner, C. Int. J. Clin. Pract., 2005, 59(12), 1428.
35. Maurer-Spurej, E. Cell. Mol. Life Sci., 2005, 6, 159.
36. Swenson, J.R.; O'Connor, C.M.; Barton, D.; Van Zyl, L.T.; Swedberg, K.; Forman, L.M.; Gaffney, M.; Glassman, A.H.; Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Am. J. Cardiol., 2003, 92(11), 1271.
37. Glassman, A.; O'Connor, R.; Califf. K. JAMA, 2002, 288, 701.
38. Berkman, L.F.; Blumenthal, J.; Burg, M.; Carney, R.M.; Catellier, D.; Cowan, M.J.; Czajkowski, S.M.; DeBusk, R.; Hosking, J.; Jaffe, A.; Kaufmann, P.G.; Mitchell, P.; Norman, J.; Powell, L.H.; Raczynski, J.M.; Schneiderman, N.; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). JAMA 2003, 289, 3106.
39. Willerson, J.T.; Eidt, J.F.; McNatt, J.; Yao, S.K.; Gotino, P.; Anderson, H.V.; Buja, L.M. J. Am. Coll. Cardiol., 1991, 17(6 suppl B), 101B.
40. Serebruany, V.L.; O'Connor, C.M.; Gurbel, P.A. Am. J. Cardiol., 2001, 87, 1398.
41. Serebruany, V.L.; Glassman, A.H.; Malinin, A.I.; Nemeroff, C.B.; Musselman, D.L.; van Zyl, L.T.; Finkel, M.S.; Krishnan, K.R.; Gaffney, M.; Harrison, W.; Califf, R.M.; O'Connor, C.M.; Sertraline AntiDepressant Heart Attack Randomized Trial Study Group. Circulation, 2003, 108, 939.
42. Pollock, B.G.; Laghrissi-Thode, F.; Wagner, W.R. J. Clin. Psychopharmacol., 2000, 20, 137.
43. Sauer, W.H.; Berlin, J.A.; Kimmel, S.E. Circulation, 2001, 104 (16), 1894.
44. Schlienger, R.G.; Fischer, L.M.; Jick, H.; Meier, C.R. Drug Saf., 2004, 27(14), 1157.
45. Serebruany, V.L.; Glassman, A.H.; Malinin, A.I.; Atar, D.; Sane, D.C.; Oshrine, B.R.; Ferguson, J.; O'Connor, C.M. Eur. J. Heart Fail., 2003, 5, 517.
46. Mann, D.L. Circulation, 1999, 100, 999.
47. Mann, D.L.; Young, J.B. Chest, 1994, 105, 897.
48. Anker, S.D.; von Haehling, S. Heart, 2004, 90, 464.
49. Adamopoulos, S.; Parissis, J.; Kremastinos, D. Eur. J. Heart Fail., 2001, 3, 517.
50. Maes, M. Adv. Exp. Med. Biol., 1999, 461, 25.
51. Pasic, J.; Levy, W.C.; Sullivan, M.D. Psychosom Med., 2003, 65, 181.
52. Watkins, L.R.; Maier, S.F.; Goehler, L.E. Life Sci., 1995, 57, 1011.
53. Reichenberg, A.; Yirmiya, R.; Schould, A.; Kraus, T.; Haack, M.; Morag, A.; Pollmacher, T. Arch. Gen. Psychiatry, 2001, 58, 445.
54. Capuron, L.; Gumnick, J.; Musselman, D.; Lawson, D.; Reemsnyder, A.; Nemeroff, C.; Miller, A. Neuropsychopharmacology, 2002, 26, 643.
55. Cassidy, E.; O'Keane, V. Br. J. Psychiatry, 2000, 176, 494.
56. Mohr, D.; Goodkin, D.; Islar, J.; Hauser, S.; Genain, C. Arch. Neurol., 2001, 58, 1081.
57. Capuron, L.; Hauser, P.; Hinze-Selch, D.; Miller, A.; Neveu, P. Brain, Behavior, Immun., 2002, 16, 575.
58. Mikova, O.; Yakimova, R.; Bosmans, E.; Kenis, G.; Maes, M. Eur. Neuropsychopharmacol., 2001, 11, 203.
59. Musselman, D.L.; Lawson, D.H.; Gumnick, J.F.; Manatunga, A.K.; Penna, S.; Goodkin, R.S.; Greiner, K.; Nemeroff, C.B.; Miller, A.H. N. Engl. J. Med., 2001, 344, 961.
60. Xia, Z.; DePierre, J.W.; Nassberger, L. Immunopharmacology, 1996, 34, 27.
61. Maes, M.; Song, C.; Li, A.; Bonaccorso, S.; Kenis, G.; De Jongh, R.; Bosmans, E.; Scharpe, S. Neuropsychopharmacology, 1999, 20, 370.
62. Suzuki, E.; Shintani, F.; Kanba; Asai, M.; Nakaki, T. Neurosc. Lett., 1996, 215, 201.
63. Maes, M. The immunoregulatory effects of antidepressants. Hum. Psychopharmacol. Clin. Exp., 2001, 16, 95.
64. Capuron, L.; Ravaud, A.; Neveu, P.J.; Miller, A.; Maes, M.; Dantzer, R. Mol. Psychiatry, 2002, 7, 468.
65. Maes, M.; Kenis, G.; Kubera, M.; De Baets, M.; Steinbusch, H.; Bosmans, E. Int. Immunopharmacol., 2005, 5(3), 609.
66. Peet M.; Murphy, B.; Shay, J.; Horrobin, D. Biol. Psychiatry, 1998, 43, 315.
67. Albert, C.M.; Campos, H.; Stampfer, M.J.; Ridker, P.; Manson, J.; Willet, W.; Ma, J.N. Engl. J. Med., 2002, 346, 1113.
68. Dunbar, S.; Kimble, L.; Jenkins, L.; Hawthorne, M.; Dudley, W.; Slemmons, M.; Langberg. J.J. Depress. Anxiety, 1999, 9, 163.
69. Whang, W.; Albert; C.M.; Sears, S.F.; Lampert, R.; Conti, J.; Wang, P; Singh, J.; Ruskin, J.; Muller, J.; Mittleman, M.; The TOVA study investigators. J. Am. Coll. Cardiol., 2005, 45, 1090.
70. Namerow, P.B.; Firth, B.R.; Heywood, G.M.; Windle, J.R.; Parides, M.K. Pacing Clin. Electrophysiol., 1999, 22, 1305.
71. Schron, E.B.; Exner, D.V.; Yao, Q.; Jenkins, L.S.; Steinberg, J.S.; Cook, J.; Kutalek, S.P.; Friedman, P.L.; Bubien, R.S.; Page, R.L.; Powell, J. Circulation, 2002, 105, 589.
72. Shores, M.; Pascually, M.; Lewis, N.; Flatness, D.; Veith, R. Psychoneuroendocrinology, 2001, 26, 433.
73. Cohen, H.; Kotler, M.; Matar, M.; Kaplan, Z. Isr. Med. Assoc. J., 2000, 2(4), 296.
74. McFarlane, A. Am. Heart J., 2001, 142, 617.
75. Carney, R.; Freedland, K.; Stein, P.; Skala, J.A.; Hoffman, P.; Jaffe, A.S. Psychosom Med., 2000, 62, 639.
76. Lara, N.; Baker, G.B.; Archer, S.L.; Le Melledo, J.M. J. Clin. Psychiatry, 2003, 64(12), 1455.
77. De Abajo, F.J.; Rodriguez, L.A.G.; Montero, D. Brit. Med. J., 1999, 319, 1106.
78. Williams, D.; Kelly, A.; Feely, J. Brit. Med. J., 2000, 320, 1405.
79. Musselman, D.L.; Marzec, U.; Davidoff, M.; Manatunga, K.; Gao, F.; Reemsnyder, A.; Duggirala, S.; Larsen, H.; Taylor, R.W.; Hanson, S.; Nemeroff, C.B. Depress. Anxiety, 2002, 15, 91.
80. Isbister, G.K.; Bowe, S.J.; Dawson, A; Whyte, I.M. J. Toxicol. Clin. Toxicol., 2004, 42(3), 277.
81. Hemeryck, A.; Belpaire, F.M. Curr. Drug Metab., 2002, 3(1), 13.
82. Mancama, D.; Kerwin, R.W. CNS Drugs, 2003, 17(3), 143.
83. Serretti, A.; Artioli, P. Pharmacogenomics J., 2004, 4(4), 233.